381 related articles for article (PubMed ID: 9420339)
21. TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia.
Mohrschladt MF; van der Sman-de Beer F; Hofman MK; van der Krabben M; Westendorp RG; Smelt AH
Eur J Hum Genet; 2005 Jul; 13(7):877-82. PubMed ID: 15856070
[TBL] [Abstract][Full Text] [Related]
22. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction.
Fumeron F; Betoulle D; Luc G; Behague I; Ricard S; Poirier O; Jemaa R; Evans A; Arveiler D; Marques-Vidal P
J Clin Invest; 1995 Sep; 96(3):1664-71. PubMed ID: 7657837
[TBL] [Abstract][Full Text] [Related]
23. Cholesteryl ester transfer protein as a protective factor against vascular disease in hemodialysis patients.
Kimura H; Miyazaki R; Suzuki S; Gejyo F; Yoshida H
Am J Kidney Dis; 2001 Jul; 38(1):70-6. PubMed ID: 11431184
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic implications of cholesteryl ester transfer protein inhibitors in hyperlipidemia and low high-density lipoprotein-cholesterolemia.
Inazu A; Mabuchi H
Curr Opin Investig Drugs; 2003 Mar; 4(3):291-7. PubMed ID: 12735230
[TBL] [Abstract][Full Text] [Related]
25. Association between the cholesteryl ester transfer protein TaqI-detectable B polymorphism and low high-density lipoprotein cholesterol concentration in Saudis.
Al-Daghri NM; Al-Attas O; Patel A; Belyaev ND; Bartlett WA; Jones AF; Kumar S; Bain SC
Clin Sci (Lond); 2003 Oct; 105(4):467-72. PubMed ID: 12773093
[TBL] [Abstract][Full Text] [Related]
26. The association of HDL cholesterol concentration with the -629C>A CETP promoter polymorphism is not fully explained by its relationship with plasma cholesteryl ester transfer.
Dullaart RP; Borggreve SE; Hillege HL; Dallinga-Thie GM
Scand J Clin Lab Invest; 2008; 68(2):99-105. PubMed ID: 17852818
[TBL] [Abstract][Full Text] [Related]
27. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.
Brousseau ME; O'Connor JJ; Ordovas JM; Collins D; Otvos JD; Massov T; McNamara JR; Rubins HB; Robins SJ; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1148-54. PubMed ID: 12117730
[TBL] [Abstract][Full Text] [Related]
28. Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study.
Frisdal E; Klerkx AH; Le Goff W; Tanck MW; Lagarde JP; Jukema JW; Kastelein JJ; Chapman MJ; Guerin M
Hum Mol Genet; 2005 Sep; 14(18):2607-18. PubMed ID: 16049032
[TBL] [Abstract][Full Text] [Related]
29. Polymorphism of the cholesteryl ester transfer protein gene.
Dullaart RP; van Tol A
N Engl J Med; 1998 May; 338(22):1625-6. PubMed ID: 9606121
[No Abstract] [Full Text] [Related]
30. Association of plasma cholesteryl ester transfer protein activity and polymorphism with coronary artery disease extent in Tunisian type II diabetic patients.
Chaaba R; Hammami S; Attia N; Smaoui M; Masmoudi AS; Mahjoub S; Ben Hamda K; Hammami M
Clin Biochem; 2005 Apr; 38(4):373-8. PubMed ID: 15766738
[TBL] [Abstract][Full Text] [Related]
31. A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency.
Moriyama Y; Okamura T; Inazu A; Doi M; Iso H; Mouri Y; Ishikawa Y; Suzuki H; Iida M; Koizumi J; Mabuchi H; Komachi Y
Prev Med; 1998; 27(5 Pt 1):659-67. PubMed ID: 9808796
[TBL] [Abstract][Full Text] [Related]
32. HDL cholesterol and TaqIB cholesteryl ester transfer protein gene polymorphism in renal transplant recipients.
Radeau T; Vohl MC; Houde I; Lachance JG; Noël R; Després JP; Douville P; Bergeron J
Nephron; 2000 Apr; 84(4):333-41. PubMed ID: 10754410
[TBL] [Abstract][Full Text] [Related]
33. Association of the cholesteryl ester transfer protein Taq1 B2B2 genotype with higher high-density lipoprotein cholesterol concentrations and lower risk of coronary artery disease in a Tunisian population.
Rejeb J; Omezzine A; Rebhi L; Naffeti I; Kchok K; Belkahla R; Bel Hadjmbarek I; Ben Rejeb N; Nabli N; Boujelbene A; Ben Abdelaziz A; Boughzala E; Bouslama A
Arch Cardiovasc Dis; 2008 Oct; 101(10):629-36. PubMed ID: 19056069
[TBL] [Abstract][Full Text] [Related]
34. TaqIB and severity of coronary artery disease in the Turkish population: a pilot study.
Kaman D; İlhan N; İlhan N; Akbulut M
Bosn J Basic Med Sci; 2015 Feb; 15(1):9-13. PubMed ID: 25725138
[TBL] [Abstract][Full Text] [Related]
35. A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men.
Liu S; Schmitz C; Stampfer MJ; Sacks F; Hennekens CH; Lindpaintner K; Ridker PM
Atherosclerosis; 2002 Apr; 161(2):469-74. PubMed ID: 11888533
[TBL] [Abstract][Full Text] [Related]
36. A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland Coronary Prevention Study.
Freeman DJ; Samani NJ; Wilson V; McMahon AD; Braund PS; Cheng S; Caslake MJ; Packard CJ; Gaffney D
Eur Heart J; 2003 Oct; 24(20):1833-42. PubMed ID: 14563342
[TBL] [Abstract][Full Text] [Related]
37. Polymorphism of the cholesteryl ester transfer protein gene.
Goldstein MR
N Engl J Med; 1998 May; 338(22):1624-5; author reply 1625-6. PubMed ID: 9606120
[No Abstract] [Full Text] [Related]
38. Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes.
van Venrooij FV; Stolk RP; Banga JD; Sijmonsma TP; van Tol A; Erkelens DW; Dallinga-Thie GM;
Diabetes Care; 2003 Apr; 26(4):1216-23. PubMed ID: 12663600
[TBL] [Abstract][Full Text] [Related]
39. High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants.
van Acker BA; Botma GJ; Zwinderman AH; Kuivenhoven JA; Dallinga-Thie GM; Sijbrands EJ; Boer JM; Seidell JC; Jukema JW; Kastelein JJ; Jansen H; Verhoeven AJ;
Atherosclerosis; 2008 Sep; 200(1):161-7. PubMed ID: 18164013
[TBL] [Abstract][Full Text] [Related]
40. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes.
Dullaart RP; Hoogenberg K; Riemens SC; Groener JE; van Tol A; Sluiter WJ; Stulp BK
Diabetes; 1997 Dec; 46(12):2082-7. PubMed ID: 9392500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
